-
2
-
-
77951569835
-
The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease
-
2-s2.0-77951569835
-
Brewer G. J., The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease. Journal of the American College of Nutrition 2009 28 3 238 242 2-s2.0-77951569835
-
(2009)
Journal of the American College of Nutrition
, vol.28
, Issue.3
, pp. 238-242
-
-
Brewer, G.J.1
-
3
-
-
81555207176
-
Issues raised involving the copper hypotheses in the causation of Alzheimer's disease
-
2-s2.0-81555207176 10.4061/2011/537528 537528
-
Brewer G. J., Issues raised involving the copper hypotheses in the causation of Alzheimer's disease. International Journal of Alzheimer's Disease 2011 2011 11 2-s2.0-81555207176 10.4061/2011/537528 537528
-
(2011)
International Journal of Alzheimer's Disease
, vol.2011
, pp. 11
-
-
Brewer, G.J.1
-
4
-
-
84862572573
-
Copper toxicity in Alzheimer's disease: Cognitive loss from ingestion of inorganic copper
-
Brewer G. J., Copper toxicity in Alzheimer's disease: cognitive loss from ingestion of inorganic copper. Journal of Trace Elements in Medicine and Biology 2012 26 2-3 89 92
-
(2012)
Journal of Trace Elements in Medicine and Biology
, vol.26
, Issue.2-3
, pp. 89-92
-
-
Brewer, G.J.1
-
5
-
-
84868521449
-
Metals in the causation and treatment of Wilson's disease and Alzheimer's disease, and copper lowering therapy in medicine
-
Brewer G. J., Metals in the causation and treatment of Wilson's disease and Alzheimer's disease, and copper lowering therapy in medicine. Inorganica Chimica Acta 2012 393 135 141
-
(2012)
Inorganica Chimica Acta
, vol.393
, pp. 135-141
-
-
Brewer, G.J.1
-
6
-
-
0022870125
-
64coppper with copper balance
-
Hill G. M., Brewer G. J., Juni J. E., Treatment of Wilson's disease with zinc. II. Validation of oral 64 coppper with copper balance. American Journal of the Medical Sciences 1986 292 6 344 349 2-s2.0-0022870125 (Pubitemid 17040561)
-
(1986)
American Journal of the Medical Sciences
, vol.292
, Issue.6
, pp. 344-349
-
-
Hill, G.M.1
Brewer, G.J.2
Juni, J.E.3
-
7
-
-
20144371701
-
Excess of serum copper not related to ceruloplasmin in Alzheimer disease
-
Squitti R., Pasqualetti P., Dal Forno G., Moffa F., Cassetta E., Lupoi D., Vernieri F., Rossi L., Baldassini M., Rossini P. M., Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 2005 64 6 1040 1046 2-s2.0-20144371701 (Pubitemid 40388458)
-
(2005)
Neurology
, vol.64
, Issue.6
, pp. 1040-1046
-
-
Squitti, R.1
Pasqualetti, P.2
Dal Forno, G.3
Moffa, F.4
Cassetta, E.5
Lupoi, D.6
Vernieri, F.7
Rossi, L.8
Baldassini, M.9
Rossini, P.M.10
-
8
-
-
33746792029
-
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
-
DOI 10.1212/01.wnl.0000223343.82809.cf, PII 0000611420060711000019
-
Squitti R., Barbati G., Rossi L., Ventriglia M., Dal Forno G., Cesaretti S., Moffa F., Caridi I., Cassetta E., Pasqualetti P., Calabrese L., Lupoi D., Rossini P. M., Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β -amyloid, and h-tau. Neurology 2006 67 1 76 82 2-s2.0-33746792029 10.1212/01.wnl.0000223343.82809.cf (Pubitemid 44305465)
-
(2006)
Neurology
, vol.67
, Issue.1
, pp. 76-82
-
-
Squitti, R.1
Barbati, G.2
Rossi, L.3
Ventriglia, M.4
Dal Forno, G.5
Cesaretti, S.6
Moffa, F.7
Caridi, I.8
Cassetta, E.9
Pasqualetti, P.10
Calabrese, L.11
Lupoi, D.12
Rossini, P.M.13
-
9
-
-
63849241137
-
Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease
-
2-s2.0-63849241137 10.1212/01.wnl.0000338568.28960.3f
-
Squitti R., Bressi F., Pasqualetti P., Bonomini C., Ghidoni R., Binetti G., Cassetta E., Moffa F., Ventriglia M., Vernieri F., Rossini P. M., Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease. Neurology 2009 72 1 50 55 2-s2.0-63849241137 10.1212/01.wnl.0000338568.28960.3f
-
(2009)
Neurology
, vol.72
, Issue.1
, pp. 50-55
-
-
Squitti, R.1
Bressi, F.2
Pasqualetti, P.3
Bonomini, C.4
Ghidoni, R.5
Binetti, G.6
Cassetta, E.7
Moffa, F.8
Ventriglia, M.9
Vernieri, F.10
Rossini, P.M.11
-
10
-
-
0029765553
-
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides
-
DOI 10.1038/ng0996-55
-
Miyata M., Smith J. D., Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β -amyloid peptides. Nature Genetics 1996 14 1 55 61 2-s2.0-0029765553 10.1038/ng0996-55 (Pubitemid 26301547)
-
(1996)
Nature Genetics
, vol.14
, Issue.1
, pp. 55-61
-
-
Miyata, M.1
Smith, J.D.2
-
11
-
-
0037075257
-
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
-
DOI 10.1056/NEJMoa011613
-
Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W. F., Wolf P. A., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. The New England Journal of Medicine 2002 346 7 476 483 2-s2.0-0037075257 10.1056/NEJMoa011613 (Pubitemid 34441738)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.7
, pp. 476-483
-
-
Seshadri, S.1
Beiser, A.2
Selhub, J.3
Jacques, P.F.4
Rosenberg, I.H.5
D'Agostino, R.B.6
Wilson, P.W.F.7
Wolf, P.A.8
-
12
-
-
0034601251
-
Are hereditary hemochromatosis mutations involved in Alzheimer disease?
-
DOI 10.1002/1096-8628(20000703)93:1 <58::AID-AJMG10>3.0.CO;2-L
-
Moalem S., Percy M. E., Andrews D. F., Are hereditary hemochromatosis mutations involved in Alzheimer disease? American Journal of Medical Genetics 2000 93 1 58 66 (Pubitemid 30350273)
-
(2000)
American Journal of Medical Genetics
, vol.93
, Issue.1
, pp. 58-66
-
-
Moalem, S.1
Percy, M.E.2
Andrews, D.F.3
Kruck, T.P.A.4
Wong, S.5
Dalton, A.J.6
Mehta, P.7
Fedor, B.8
Warren, A.C.9
-
13
-
-
0347764583
-
Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians
-
Zambenedetti P., De Bellis G., Biunno I., Musicco M., Zatta P., Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. Journal of Alzheimer's Disease 2003 5 6 423 427 2-s2.0-0347764583 (Pubitemid 38101229)
-
(2003)
Journal of Alzheimer's Disease
, vol.5
, Issue.6
, pp. 423-427
-
-
Zambenedetti, P.1
De Bellis, G.2
Biunno, I.3
Musicco, M.4
Zatta, P.5
-
14
-
-
80052662795
-
Association between the c. 2495 A>G ATP7B polymorphism and sporadic Alzheimer's disease
-
2-s2.0-80052662795 10.4061/2011/973692 973692
-
Bucossi S., Mariani S., Ventriglia M., Polimanti R., Gennarelli M., Bonvicini C., Pasqualetti P., Scrascia F., Migliore S., Vernieri F., Rossini P. M., Squitti R., Association between the c. 2495 A>G ATP7B polymorphism and sporadic Alzheimer's disease. International Journal of Alzheimer's Disease 2011 2011 9 2-s2.0-80052662795 10.4061/2011/973692 973692
-
(2011)
International Journal of Alzheimer's Disease
, vol.2011
, pp. 9
-
-
Bucossi, S.1
Mariani, S.2
Ventriglia, M.3
Polimanti, R.4
Gennarelli, M.5
Bonvicini, C.6
Pasqualetti, P.7
Scrascia, F.8
Migliore, S.9
Vernieri, F.10
Rossini, P.M.11
Squitti, R.12
-
15
-
-
77957940736
-
Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease
-
2-s2.0-77957940736 10.1177/1533317510382283
-
Brewer G. J., Kanzer S. H., Zimmerman E. A., Molho E. S., Celmins D. F., Heckman S. M., Dick R., Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. American Journal of Alzheimer's Disease and other Dementias 2010 25 7 572 575 2-s2.0-77957940736 10.1177/1533317510382283
-
(2010)
American Journal of Alzheimer's Disease and Other Dementias
, vol.25
, Issue.7
, pp. 572-575
-
-
Brewer, G.J.1
Kanzer, S.H.2
Zimmerman, E.A.3
Molho, E.S.4
Celmins, D.F.5
Heckman, S.M.6
Dick, R.7
-
16
-
-
77949423502
-
Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability
-
2-s2.0-77949423502 10.1007/s10534-009-9277-5
-
Baum L., Chan I. H. S., Cheung S. K.-K., Goggins W. B., Mok V., Lam L., Leung V., Hui E., Ng C., Woo J., Chiu H. F. K., Zee B. C.-Y., Cheng W., Chan M.-H., Szeto S., Lui V., Tsoh J., Bush A. I., Lam C. W. K., Kwok T., Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals 2010 23 1 173 179 2-s2.0-77949423502 10.1007/s10534-009-9277-5
-
(2010)
Biometals
, vol.23
, Issue.1
, pp. 173-179
-
-
Baum, L.1
Chan, I.H.S.2
Cheung, S.K.-K.3
Goggins, W.B.4
Mok, V.5
Lam, L.6
Leung, V.7
Hui, E.8
Ng, C.9
Woo, J.10
Chiu, H.F.K.11
Zee, B.C.-Y.12
Cheng, W.13
Chan, M.-H.14
Szeto, S.15
Lui, V.16
Tsoh, J.17
Bush, A.I.18
Lam, C.W.K.19
Kwok, T.20
more..
-
17
-
-
79251579593
-
Insight into glutamate excitotoxicity from synaptic zinc homeostasis
-
2-s2.0-79251579593 10.4061/2011/491597 491597
-
Takeda A., Insight into glutamate excitotoxicity from synaptic zinc homeostasis. International Journal of Alzheimer's Disease 2011 2011 8 2-s2.0-79251579593 10.4061/2011/491597 491597
-
(2011)
International Journal of Alzheimer's Disease
, vol.2011
, pp. 8
-
-
Takeda, A.1
-
18
-
-
80052684579
-
The Alzheimer's therapeutic PBT2 promotes amyloid- β degradation and GSK3 phosphorylation via a metal chaperone activity
-
2-s2.0-80052684579 10.1111/j.1471-4159.2011.07402.x
-
Crouch P. J., Savva M. S., Hung L. W., Donnelly P. S., Mot A. I., Parker S. J., Greenough M. A., Volitakis I., Adlard P. A., Cherny R. A., Masters C. L., Bush A. I., Barnham K. J., White A. R., The Alzheimer's therapeutic PBT2 promotes amyloid- β degradation and GSK3 phosphorylation via a metal chaperone activity. Journal of Neurochemistry 2011 119 1 220 230 2-s2.0-80052684579 10.1111/j.1471-4159.2011.07402.x
-
(2011)
Journal of Neurochemistry
, vol.119
, Issue.1
, pp. 220-230
-
-
Crouch, P.J.1
Savva, M.S.2
Hung, L.W.3
Donnelly, P.S.4
Mot, A.I.5
Parker, S.J.6
Greenough, M.A.7
Volitakis, I.8
Adlard, P.A.9
Cherny, R.A.10
Masters, C.L.11
Bush, A.I.12
Barnham, K.J.13
White, A.R.14
-
19
-
-
76149093866
-
Cognitive loss in zinc transporter-3 knock-out mice: A phenocopy for the synaptic and memory deficits of Alzheimer's disease?
-
2-s2.0-76149093866 10.1523/JNEUROSCI.5255-09.2010
-
Adlard P. A., Parncutt J. M., Finkelstein D. I., Bush A. I., Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? Journal of Neuroscience 2010 30 5 1631 1636 2-s2.0-76149093866 10.1523/JNEUROSCI.5255-09.2010
-
(2010)
Journal of Neuroscience
, vol.30
, Issue.5
, pp. 1631-1636
-
-
Adlard, P.A.1
Parncutt, J.M.2
Finkelstein, D.I.3
Bush, A.I.4
-
20
-
-
0026783899
-
Treatment of Alzheimer's disease by zinc compounds
-
2-s2.0-0026783899
-
Constantinidis J., Treatment of Alzheimer's disease by zinc compounds. Drug Development Research 1992 27 1 1 14 2-s2.0-0026783899
-
(1992)
Drug Development Research
, vol.27
, Issue.1
, pp. 1-14
-
-
Constantinidis, J.1
-
21
-
-
79952638895
-
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction
-
2-s2.0-79952638895 10.1038/cddis.2010.73
-
Corona C., Masciopinto F., Silvestri E., Viscovo A. D., Lattanzio R., Sorda R. L., Ciavardelli D., Goglia F., Piantelli M., Canzoniero L. M., Sensi S. L., Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death & Disease 2010 1, article e91 2-s2.0-79952638895 10.1038/cddis.2010.73
-
(2010)
Cell Death & Disease
, vol.191
-
-
Corona, C.1
Masciopinto, F.2
Silvestri, E.3
Viscovo, A.D.4
Lattanzio, R.5
Sorda, R.L.6
Ciavardelli, D.7
Goglia, F.8
Piantelli, M.9
Canzoniero, L.M.10
Sensi, S.L.11
-
22
-
-
0032191253
-
Treatment of Wilson's disease with zinc: XV long-term follow-up studies
-
Brewer G. J., Dick R. D., Johnson V. D., Brunberg J. A., Kluin K. J., Fink J. K., Treatment of Wilson's disease with zinc: XV long-term follow-up studies. Journal of Laboratory and Clinical Medicine 1998 132 4 264 278 2-s2.0-0032191253 (Pubitemid 28490259)
-
(1998)
Journal of Laboratory and Clinical Medicine
, vol.132
, Issue.4
, pp. 264-278
-
-
Brewer, G.J.1
Dick, R.D.2
Johnson, V.D.3
Brunberg, J.A.4
Kluin, K.J.5
Fink, J.K.6
-
23
-
-
0020006080
-
Ceruloplasmin: Methods and clinical use
-
2-s2.0-0020006080
-
Wolf P. L., Ceruloplasmin: methods and clinical use. Critical Reviews in Clinical Laboratory Sciences 1982 17 3 229 245 2-s2.0-0020006080
-
(1982)
Critical Reviews in Clinical Laboratory Sciences
, vol.17
, Issue.3
, pp. 229-245
-
-
Wolf, P.L.1
|